Know Cancer

or
forgot password

Molecular Studies and Clinical Correlations in Human Prostatic Disease


N/A
N/A
N/A
Open (Enrolling)
Male
Prostate Cancer

Thank you

Trial Information

Molecular Studies and Clinical Correlations in Human Prostatic Disease


The therapeutics program for advanced prostate cancer is based on the hypothesis that the
factors contributing to and associated with progression change as the disease evolves. To
categorize these changes we now consider the disease as a series of states. 1 The states
represent points where an intervention might be considered to prevent cancer from
developing, to eliminate established disease, or to delay progression. The states also
represent clinically significant milestones that can be used to assess treatment effects.


Inclusion Criteria:



Men with prostate conditions representing the following disease states:

- No Cancer Diagnosis

- Clinically Localized Disease

- Rising PSA

- Clinical Metastases: Noncastrate

- Clinical Metastases: Castrate (Testosterone ≤ 50 ng/ml)

- Signed informed consent

Exclusion Criteria:

-Patients without any prostate related problems.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only

Principal Investigator

Susan Slovin, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

90-040

NCT ID:

NCT00578240

Start Date:

April 1990

Completion Date:

December 2014

Related Keywords:

  • Prostate Cancer
  • benign
  • Rising PSA
  • Clinical Metastases
  • 90-040
  • Prostatic Diseases
  • Prostatic Neoplasms

Name

Location

Memorial Sloan-Kettering Cancer CenterNew York, New York  10021